<code id='A3E4136825'></code><style id='A3E4136825'></style>
    • <acronym id='A3E4136825'></acronym>
      <center id='A3E4136825'><center id='A3E4136825'><tfoot id='A3E4136825'></tfoot></center><abbr id='A3E4136825'><dir id='A3E4136825'><tfoot id='A3E4136825'></tfoot><noframes id='A3E4136825'>

    • <optgroup id='A3E4136825'><strike id='A3E4136825'><sup id='A3E4136825'></sup></strike><code id='A3E4136825'></code></optgroup>
        1. <b id='A3E4136825'><label id='A3E4136825'><select id='A3E4136825'><dt id='A3E4136825'><span id='A3E4136825'></span></dt></select></label></b><u id='A3E4136825'></u>
          <i id='A3E4136825'><strike id='A3E4136825'><tt id='A3E4136825'><pre id='A3E4136825'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:759
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In